Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease

INTRODUCTION: Alzheimer’s disease (AD) is the most common cause of dementia, characterized by progressive cognitive decline. Protein biomarkers of AD brain pathology, including β-amyloid and Tau, are reflected in cerebrospinal fluid (CSF), yet the identification of additional biomarkers linked to ot...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Maotian, Haque, Rafi U., Dammer, Eric B., Duong, Duc M., Ping, Lingyan, Johnson, Erik C. B., Lah, James J., Levey, Allan I., Seyfried, Nicholas T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257173/
https://www.ncbi.nlm.nih.gov/pubmed/32514259
http://dx.doi.org/10.1186/s12014-020-09285-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257173/
https://www.ncbi.nlm.nih.gov/pubmed/32514259
http://dx.doi.org/10.1186/s12014-020-09285-8

Ejemplares similares